Clinical Trials

NCT Number: NCT05471414 Phase: Not Applicable Trial Summary: The study is comparing the effect on weight of providing home-delivered whole-food, plant-based meals versus standard, general nutritional counseling to men with prostate cancer on androgen-deprivatio – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Weill Medical College of Cornell University Acronym: WFPBD

NCT Number: NCT05754658 Phase: Trial Summary: he goal of this study is to develop a comprehensive characterization of genetic and molecular drivers of breast and prostate cancer in individuals of – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Fox Chase Cancer Center Acronym:

NCT Number: NCT05946213 Phase: PHASE3 Trial Summary: This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): NRG Oncology Acronym:

NCT Number: NCT06085664 Phase: PHASE1|PHASE2 Trial Summary: To learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer. – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): M.D. Anderson Cancer Center Acronym:

NCT Number: NCT06218667 Phase: PHASE1|PHASE2 Trial Summary: The researchers are doing this study to find out whether copanlisib in combination with degarelix, given before standard surgical treatment (radical prostatectomy), is a safe and effective treatment t – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Memorial Sloan Kettering Cancer Center Acronym:

NCT Number: NCT05708950 Phase: Phase 1|Phase 2 Trial Summary: The goal of this clinical trial is to test the safety and efficacy of KVA12123 alone or combined with pembrolizumab in patients with advanced solid tumors.… – see link above for mo – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Kineta Inc. Acronym:

NCT Number: NCT05838716 Phase: PHASE3 Trial Summary: This phase III trial tests whether high-dose vitamin D works in treating androgen-deprivation therapy (ADT)-induced bone loss in patients with prostate cancer who are undergoing androgen-deprivation t – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Rochester NCORP Research Base Acronym:

NCT Number: NCT04777071 Phase: Phase 2 Trial Summary: This trial studies how well 68Ga-PSMA-11 PET/CT scan works in imaging patients with prostate cancer. Diagnostic procedures, such as 68Ga-PSMA-11 PET/CT may find and diagnose prosta – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Washington Acronym:

NCT Number: NCT06128525 Phase: NA Trial Summary: This phase I trial tests the safety of magnetic resonance imaging (MRI)/ ultrasound (US) fusion guided transperineal targeted microwave ablation (TMA) before a radical prostatectomy (RP) and how well – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Southern California Acronym:

NCT Number: NCT04768868 Phase: Phase 1 Trial Summary: A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Impact Therapeutics, Inc. Acronym: WEE1